Clinical Trial Update: PULSAR Combined With Immunotherapy and Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating PULSAR in combination with immunotherapy and chemotherapy for cholangiocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• PULSAR

Snippet

Sponsor: Wang Xin | Conditions: Cholangiocarcinoma | Phase 1, Phase 2 | Status: RECRUITING